Showing 1 - 10 of 13
This paper examines the tax treatment of pensioners in 15 industrialised countries. Using a standard methodology, it calculates the average and marginal tax rates of older people and compares them with those of people of working age. These are then combined with a model of pension entitlements...
Persistent link: https://www.econbiz.de/10005811293
Persistent link: https://www.econbiz.de/10001903419
Persistent link: https://www.econbiz.de/10001831127
Persistent link: https://www.econbiz.de/10006823487
Most countries give income-tax concessions to older people relative to people of working age. Some treat pension income more favourably than earnings, and most do not levy social security contributions on older people. These policies mean that the direct tax burden of older people is lower than...
Persistent link: https://www.econbiz.de/10012446981
Persistent link: https://www.econbiz.de/10009597404
This paper describes and assesses pharmaceutical pricing and reimbursement policies in Canada, considering them in the context of the broader policy and market environment in which they operate, and investigating their role in contributing to Canada’s achievements in meeting a range of...
Persistent link: https://www.econbiz.de/10005049185
This paper examines aspects of the policy environment and market characteristics of the Swedish pharmaceutical sector, assesses the degree to which Sweden has achieved certain policy goals, and puts forth some key findings and conclusions. Thanks to low mark-ups in the distribution chain and no...
Persistent link: https://www.econbiz.de/10005049187
This paper examines aspects of the policy environment and market characteristics of Slovakia's pharmaceutical sector, and assesses the degree to which Slovakia has achieved certain policy goals. Pharmaceutical expenditure in Slovakia accounts for a higher share of total health expenditure than...
Persistent link: https://www.econbiz.de/10005049192
This paper examines aspects of the policy environment and market characteristics of Mexico's pharmaceutical sector, and assesses the degree to which Mexico has achieved certain policy goals. This paper questions the effectiveness of the maximum price regulation. It notes that retail prices for...
Persistent link: https://www.econbiz.de/10005049202